[go: up one dir, main page]

US20080161392A1 - Liquid concentrate for the preservation of cosmetic and pharmaceutical products - Google Patents

Liquid concentrate for the preservation of cosmetic and pharmaceutical products Download PDF

Info

Publication number
US20080161392A1
US20080161392A1 US12/049,397 US4939708A US2008161392A1 US 20080161392 A1 US20080161392 A1 US 20080161392A1 US 4939708 A US4939708 A US 4939708A US 2008161392 A1 US2008161392 A1 US 2008161392A1
Authority
US
United States
Prior art keywords
concentrate
glycol
weight
acid
ipbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/049,397
Inventor
Gisela Hahn
Klaus Weber
Ralf Gradtke
Wolfgang Beilfuss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Priority to US12/049,397 priority Critical patent/US20080161392A1/en
Assigned to L'AIR LIQUIDE SANTE (INTERNATIONAL) reassignment L'AIR LIQUIDE SANTE (INTERNATIONAL) ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BEILFUSS, WOLFGANG, GRADTKE, RALF, HAHN, GISELA, WEBER, KLAUS
Publication of US20080161392A1 publication Critical patent/US20080161392A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/526—Corrosion inhibitors

Definitions

  • the invention relates to a liquid concentrate based on 3-iodo-2-propynyl butylcarbamate (IPBC) and to its use in the preparation and preservation of cosmetic and pharmaceutical products.
  • IPBC 3-iodo-2-propynyl butylcarbamate
  • Preservatives are used in many products or systems with an aqueous phase in order to avoid harmful and spoiling effects, in particular microbial effects, on the product.
  • Important fields of use of preservatives are cosmetic products, such as shampoos, shower gels and bath gels, but also high-value care cosmetics, such as creams, emulsions, lotions and gels.
  • Preservatives are also used in cleaning, care and hygiene products for the home (e.g. antimicrobial hand cleansers) and body care (e.g. toothpaste).
  • IPBC has of late played an ever greater role in the preservation of such products. It is available as a white powder and has the disadvantage that it is only very sparingly soluble in water (approximately 0.1 g/l at 20° C.). In the solid form, it has performance disadvantages with regard to handling and metering. For this reason, industry prefers to fall back on liquid products and is interested in a liquid IPBC form.
  • EP 0 757 518 is known, in accordance with which combinations of IPBC with formaldehyde-depositing compounds are used.
  • a further example of known IPBC formulations is EP 0 484 172, in which combinations of IPBC with 1,3,5-tris(hydroxyethyl)hexahydrotriazine are described.
  • DE 100 34 138 which describes combinations of IPBC with phenoxyethanol, is also known.
  • IPBC is actually sufficiently soluble in most organic solvents and compatible with many active agents, additives and auxiliaries used in cosmetics, yet the colour stability of liquid concentrates still causes great problems, which can be put down to their low solubility in water and their active groups in the IPBC molecule. Sensitivity to light, heat and oxidation are to be added, resulting in the formation of coloured decomposition products. Odour development is also frequently inadequate.
  • a liquid concentrate for the preservation of cosmetic and pharmaceutical products based on 3-iodo-2-propynyl butylcarbamate (IPBC) is proposed to achieve this object, which liquid concentrate is characterized in that it, in addition to IPBC, comprises a liquid carrier chosen from polyvalent alcohols, glycol esters and glycol ethers or any mixture thereof and a stabilizer chosen from formic acid, formate salts and formate esters or any mixture thereof, no additional carboxylic acid chosen from benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid or a salt thereof being present.
  • a liquid carrier chosen from polyvalent alcohols, glycol esters and glycol ethers or any mixture thereof and a stabilizer chosen from formic acid, formate salts and formate esters or any mixture thereof, no additional carboxylic acid chosen from benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid
  • colour-stabilizing action means that the concentrate, optionally diluted with solvent or in the product to be preserved, is subject to no obvious colour change (e.g. turning brown) under conventional storage conditions. Such a colour change can, for example, be monitored with known test methods (e.g. determination of the Hazen colour number or Gardner colour number).
  • active agent stability means that, under conventional storage conditions over a period of at least 4 weeks, preferably 3 months, no precipitate perceptible by the senses or no cloudiness appears in the concentrate.
  • Conventional storage conditions is to be understood, for example, as storage at ambient temperatures from 15 to 25° C. in dry, ventilated spaces.
  • the liquid concentrate according to the invention also exhibits an improved storage stability over the period mentioned at temperatures which are clearly higher than conventional storage temperatures, preferably higher than 40° C. (e.g. 50° C.), which is particularly advantageous for use thereof in tropical regions.
  • the invention also relates to a process for the preparation of such a liquid concentrate and to the use of the liquid concentrate according to the invention in the preparation and/or preservation of cosmetic and pharmaceutical products.
  • the liquid concentrate according to the invention comprises IPBC, with reference to the total weight, in an amount of 0.01 up to 20 weight % of IPBC, preferably 0.1 up to 5 weight % of IPBC, especially 0.1 up to 2 weight % of IPBC and particularly preferably up to 1 weight % of IPBC.
  • the liquid concentrate comprises, as liquid carrier, a polyvalent alcohol, in particular a diol, preferably a glycol and more preferably ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentane-diol or 1,5-pentanediol, or a glycol ester or glycol ether, in particular an ethylene glycol, propylene glycol or butylene glycol, preferably diethylene glycol, triethylene glycol or a polyethylene glycol, or any mixture thereof. Triethylene glycol or 1,2-propylene glycol are particularly preferred.
  • a polyvalent alcohol in particular a diol, preferably a glycol and more preferably ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glyco
  • the amount of liquid carrier present in the liquid concentrate according to the invention ranges, with reference to the total weight, from 30 to 99.989 weight %; it preferably amounts to at least 50 weight % and especially at least 95 weight %.
  • the stabilizer component of the liquid concentrate is chosen from formic acid, sodium formate, potassium formate, formic acid propylene glycol mono- or diester or formate esters formed in situ or any mixture thereof, in particular formic acid. 85% or 98-100% formic acid can, for example, be used.
  • the stabilizer component is present therein in an amount of 0.001 to 20 weights, preferably 0.05 to 10weight %, more preferably still 0.05 to 5 or to 2 weight % and for example less than 2 or less than 0.5 weight % or even less than 0.2 weight %.
  • the liquid concentrate can comprise additional active agents, functional additives and/or auxiliaries.
  • Polybiguanide (frequently also described as polyhexamethylenebiguanide hydrochloride) and/or a polybiguanide salt is possible as additional active agent, preferably in an amount, with reference to the total weight, of 0.1 up to 20 weight %, more preferably up to 5 weight %, particularly preferably up to 2 weight % and most preferably up to 1 weight %.
  • additional active agent preferably in an amount, with reference to the total weight, of 0.1 up to 20 weight %, more preferably up to 5 weight %, particularly preferably up to 2 weight % and most preferably up to 1 weight %.
  • a 20% polyhexamethylenebiguanide hydrochloride in anhydrous or virtually anhydrous grade can be used.
  • the weight ratio of IPBC to polybiguanide or polybiguanide salt is in a preferred embodiment 100:1 to 1:100, preferably 10:1 to 1:10 and more preferably 1:2 to 2:1.
  • the concentrate comprises ⁇ 1 weight % of IPBC, in particular 1 weight %, and ⁇ 1 weight % of polybiguanide/polybiguanide salt, in particular 0.95 weight %.
  • the liquid concentrate is either anhydrous or comprises water as auxiliary, the content of water then preferably amounting to, based on the total weight, 0.01 up to 10 weight %, more preferably up to 5 weight %, more preferably still up to 4.5 or up to 4 weight %, particularly preferably up to 0.2 weight % (virtually anhydrous).
  • the liquid concentrates are preferably anhydrous or virtually anhydrous.
  • the liquid concentrate can comprise, as additional active agent, in addition to or in place of the polybiguanide compound, a paraben, in particular methyl-, ethyl-, propyl- or butylparaben, a quaternary ammonium compound, in particular polyhexamethylene-biguanide or a salt thereof, a benzalkonium salt, in particular benzalkonium chloride, formaldehyde or a formaldehyde-depositing compound or a salt thereof, in particular dimethyloldimethylhydantoin (DMDMH), imidazolidinylurea, diazolidinylurea, hexetidine, 5-bromo-5-nitro-1,3-dioxane (bronidox), 2-bromo-2-nitro-1,3-propanediol (bronopol), 1,3,5,7-tetraazaadamantane (hexamethylenetetramine), 4,4-dimethyl1,3-oxazolidine
  • Preferred antimicrobial active agents which can be used to improve the effectiveness and/or to broaden the spectrum of activity are o-phenylphenol and its salts, zinc pyrithione, inorganic sulphites and bisulphites, sodium iodate, dibromohexamidine and its salts, triclocarban, 4-chloro-m-cresol, triclosan, 4-chloro-3,5-dimethylphenol, 2-hydroxy-4,4′-dichlorophenyl ether (e.g.
  • Tinosan HP 100 polyhexamethylenediguanide and its salts, 1-(4-chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethyl-2-butanone, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) -2-pyridone and its monoethanolamine salt, 1,2-dibromo-2,4-dicyanobutane, bromochlorophen, 5-chloro-2-methyl-3(2H)-isothiazolone, 2-methyl-3(2H)-isothiazolone, 2-benzyl-4-chlorophenol, 2-chloroacetamide, chlorohexidine and its salts, N-[(C 12 -C 22 )alkyltrimethyl]ammonium salts, hexamidine and its salts, glutaraldehyde, silver chloride, benzethonium chloride, benzalkonium salts (e.g. benzalkonium chloride), or
  • auxiliaries or active agents for the basic formulation (in place of the acids mentioned below, the corresponding salts are optionally used).
  • the additives can be anion-active or cation-active.
  • examples of additives are skin care substances and moisture-retaining factors (e.g. urea or Sensiva SC 50), complexing agents (e.g. EDTA), essential oils and natural extracts, amphoteric surfactants, surfactants, cleaning additives and disinfection active agents (e.g. cocoamidopropyl betaine), fragrances, antiacne or antidandruff active agents (e.g.
  • octopirox and Lipacid C8G fungicides, dyes, corrosion inhibitors, disinfection active agents and antiseptics (e.g. octenidine dihydrochloride), bitter principals (e.g. denatonium salts), screening agents (e.g. 2-phenylbenzimidazolesulphonic acid), deodorant active agents (e.g. zinc phenolsulphonate or Sensiva SC 50), oral care active agents (e.g. potassium monofluorophosphate), isothiazolones, carbohydrate compounds (e.g. alkylpolyglycosides, starch or cellulose derivatives and cyclodextrins), alkali metal chlorides (e.g.
  • Quaternary ammonium salts e.g. cetyltrimethylammonium chloride or bromide, cetylpyridinium chloride or didecyldimethylammonium chloride
  • auxiliaries and/or active agents are, for example, thickeners, buffers, antifoaming agents, solubility promoters, antistatic agents, polymers and/or antioxidants.
  • the type and amount of additional active agents can be established by a person skilled in the art in a simple and rapid manner by a few experiments, it being possible for the active agent system obtained, which includes the liquid concentrate according to the invention, to have a broad or also very specific application potential.
  • the preparation of the concentrates is carried out by simple mixing.
  • the solid components are dissolved with stirring in the liquid components and the additional additives and auxiliaries are stirred in homogeneously.
  • the mixture is optionally heated (e.g. up to 50° C.
  • the liquid concentrate is stirred or allowed to stand at an increased temperature for a period of time.
  • This temperature treatment results in a surprisingly increased stability.
  • the mixture is advantageously, subsequent to the mixing together, held for 0.5 to 48 hours at a temperature of 30 to 70° C., optionally with stirring, in particular 30 up to 60° C., more preferably at 30 up to 50° C.
  • a temperature treatment over 6 h at 50° C., 24 h at 40° C. or 48 h at 30° C. is possible. The higher the temperature, the shorter the period of time of the temperature treatment can be.
  • liquid concentrates according to the invention can be incorporated in the cosmetic and pharmaceutical products by simple dilution. This offers handling and cost advantages compared with the use of individual substances, which are often powders or granules and have to be dissolved or dispersed before incorporation in the product to be preserved. Storage and transportation costs can also be reduced by the concentrate form.
  • liquid concentrates according to the invention are suitable as solubility promoters for cosmetic additives with little or limited solubility in water or as solvents or carriers for various cosmetic additives.
  • the liquid concentrate according to the invention preferably exists as a clear homogeneous solution. However, should precipitates possibly arise at a low pH in the concentrate or in predilutions, these can be reversibly dissolved by simple dilution or by correcting the pH. However, it is also possible to prepare the liquid concentrate as a homogeneous-disperse preparation, it being preferable in such cases to avoid relatively large amounts of crystallized active agents in the preparation. In addition, the liquid concentrate can exist in the form of a paste.
  • an “aged” mixture of glycols and/or glycol ethers and formic acid is used as carrier/stabilizer combination.
  • the expression “aged” means in this connection that combinations of glycols and/or glycol ethers and. formic acid are held at an increased temperature (up to boiling point of the mixture) for a sufficiently long period of time, optionally with stirring, until the smell of formic acid has largely or completely disappeared. Ester formation between the formic acid and the glycol and/or glycol ether possibly occurs during this ageing, the exact structure of the compounds formed being unknown.
  • glycol (ether) formates can also be dissolved in glycol and/or glycol ether and the combination can be used together with the IPBC.
  • Liquid concentrates which smell very little or not at all of formic acid are particularly preferred.
  • the pH of the liquid concentrate is 1 to 10, preferably 3 to 7 and preferably 5 to 7 (measured after preparation of a fresh solution or emulsion with water).
  • the pH of a 2 weight % solution/emulsion in water ranges from 2.5 to 5.5 or approximately 3.
  • liquid concentrates according to the invention therefore have, in particular, the following advantages:
  • the liquid concentrates according to the invention are suitable for the preparation of cosmetic products, in particular for leave-on products, such as creams, lotions, gels or moist wipes, the pH values of which generally range from 5 to 8, or for rinse-off products, such as shampoos, the pH values of which are generally less than 7, in particular less than 6.
  • liquid concentrates according to the invention are suitable as additive for pharmaceutical products and for washing, cleaning, care, body care and hygiene products.
  • the concentrates according to the invention contribute to the antimicrobial effectiveness.
  • polybiguanide was used as a 20 weight % product in water; i.e. 4.75 weight % of 20% polybiguanide corresponds to 0.95 weight % of active agent.
  • IPBC 0.95 weight % IPBC 4.75 weight % 20% Polybiguanide 2.20 weight % Formic acid (85% in water) 92.10 weight % 1,2-Propylene glycol
  • the examples according to the invention all showed good stability with regard to odour, colour and active agent, while the products of the comparative examples did not display sufficient stability with regard to odour, colour and active agent.
  • the liquid concentrates were stored in clear glass and the Hazen or Gardner colour number (see test methods) was determined immediately after preparation on a freshly produced preparation, and also after the period of time given and storage at the temperatures given,
  • the Hazen colour number (DIN-ISO 6271, also known as “APHA method” or “platinum/cobalt scale”) is defined as mg of platinum per 1 litre of solution.
  • APHA method platinum/cobalt scale
  • For the Hazen stock solution 1.246 g of potassium hexachloroplatinate(IV) and 1.00 g of cobalt(II) chloride are dissolved in 100 ml of hydrochloric acid and made up to 1,000 ml with distilled water,
  • the Hazen colour scale is used for assessing the colour of products which are almost limpid. It is graduated more closely in the light-yellowish region than the iodine colour scale and extends as far as limpid shades of colour.
  • the Gardner colour number is defined in DIN-ISO 4630.
  • the light-yellow Gardner colour numbers (1 to 8) are based on potassium chloroplatinate solutions and the colour numbers 9 to 18 on iron(III) chloride, cobalt(II) chloride and hydrochloric acid solutions.
  • the respective concentrate was introduced into a cell and then the colour number was measured using a colorimeter of Lico® 2 00 type (Dr Lange GmbH, Berlin).
  • the odour development was examined organoleptically.
  • the odours were in each case assessed by 3 people.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a liquid concentrate for the preservation of cosmetic an pharmaceutical prod nets which comprises 3-iodo-2-propynyl butylcarbamate (IPBC), at least on liquid carrier selected from the group consisting of: polyvalent alcohols, glycol esters and glycol ethers, and at least one stabilizer selected from the group consisting of: formic acid, formic acid salts, and format esters, and comprising no additional carboxylic acid selected from the group consisting of: benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid and a salt thereof being present.

Description

  • The invention relates to a liquid concentrate based on 3-iodo-2-propynyl butylcarbamate (IPBC) and to its use in the preparation and preservation of cosmetic and pharmaceutical products.
  • Preservatives are used in many products or systems with an aqueous phase in order to avoid harmful and spoiling effects, in particular microbial effects, on the product. Important fields of use of preservatives are cosmetic products, such as shampoos, shower gels and bath gels, but also high-value care cosmetics, such as creams, emulsions, lotions and gels. Preservatives are also used in cleaning, care and hygiene products for the home (e.g. antimicrobial hand cleansers) and body care (e.g. toothpaste).
  • IPBC has of late played an ever greater role in the preservation of such products. It is available as a white powder and has the disadvantage that it is only very sparingly soluble in water (approximately 0.1 g/l at 20° C.). In the solid form, it has performance disadvantages with regard to handling and metering. For this reason, industry prefers to fall back on liquid products and is interested in a liquid IPBC form.
  • In addition, the colour of the products is assuming an ever greater role. Colourless or pastel-coloured products, which furthermore should have a high colour stability, are increasingly desired.
  • For example, EP 0 757 518 is known, in accordance with which combinations of IPBC with formaldehyde-depositing compounds are used. A further example of known IPBC formulations is EP 0 484 172, in which combinations of IPBC with 1,3,5-tris(hydroxyethyl)hexahydrotriazine are described. DE 100 34 138, which describes combinations of IPBC with phenoxyethanol, is also known.
  • IPBC is actually sufficiently soluble in most organic solvents and compatible with many active agents, additives and auxiliaries used in cosmetics, yet the colour stability of liquid concentrates still causes great problems, which can be put down to their low solubility in water and their active groups in the IPBC molecule. Sensitivity to light, heat and oxidation are to be added, resulting in the formation of coloured decomposition products. Odour development is also frequently inadequate.
  • It is therefore an object of the present invention to make available a liquid product in the form of a liquid concentrate for the preservation of cosmetic and pharmaceutical products based on IPBC which is colour-stable, which, in addition to the pronounced fungicidal action, also shows a very good bactericidal action, which also is stable with reference to the active agent content and which has good organoleptic properties.
  • A liquid concentrate for the preservation of cosmetic and pharmaceutical products based on 3-iodo-2-propynyl butylcarbamate (IPBC) is proposed to achieve this object, which liquid concentrate is characterized in that it, in addition to IPBC, comprises a liquid carrier chosen from polyvalent alcohols, glycol esters and glycol ethers or any mixture thereof and a stabilizer chosen from formic acid, formate salts and formate esters or any mixture thereof, no additional carboxylic acid chosen from benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid or a salt thereof being present.
  • The proportions of the individual components in the liquid concentrate given below in weight % refer to the weight of the combined concentrate, unless otherwise specified.
  • It has surprisingly been shown that, through the combination of IPBC with a liquid carrier and one of the formic acid derivatives mentioned as stabilizer, a product is obtained which has a stable colour, a stable active agent and an acceptable odour, without the microbiological activity being reduced.
  • In this connection, “colour-stabilizing action” means that the concentrate, optionally diluted with solvent or in the product to be preserved, is subject to no obvious colour change (e.g. turning brown) under conventional storage conditions. Such a colour change can, for example, be monitored with known test methods (e.g. determination of the Hazen colour number or Gardner colour number).
  • The term “active agent stability” means that, under conventional storage conditions over a period of at least 4 weeks, preferably 3 months, no precipitate perceptible by the senses or no cloudiness appears in the concentrate. “Conventional storage conditions” is to be understood, for example, as storage at ambient temperatures from 15 to 25° C. in dry, ventilated spaces. However, the liquid concentrate according to the invention also exhibits an improved storage stability over the period mentioned at temperatures which are clearly higher than conventional storage temperatures, preferably higher than 40° C. (e.g. 50° C.), which is particularly advantageous for use thereof in tropical regions.
  • The invention also relates to a process for the preparation of such a liquid concentrate and to the use of the liquid concentrate according to the invention in the preparation and/or preservation of cosmetic and pharmaceutical products.
  • The liquid concentrate according to the invention comprises IPBC, with reference to the total weight, in an amount of 0.01 up to 20 weight % of IPBC, preferably 0.1 up to 5 weight % of IPBC, especially 0.1 up to 2 weight % of IPBC and particularly preferably up to 1 weight % of IPBC.
  • The liquid concentrate comprises, as liquid carrier, a polyvalent alcohol, in particular a diol, preferably a glycol and more preferably ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentane-diol or 1,5-pentanediol, or a glycol ester or glycol ether, in particular an ethylene glycol, propylene glycol or butylene glycol, preferably diethylene glycol, triethylene glycol or a polyethylene glycol, or any mixture thereof. Triethylene glycol or 1,2-propylene glycol are particularly preferred.
  • The amount of liquid carrier present in the liquid concentrate according to the invention ranges, with reference to the total weight, from 30 to 99.989 weight %; it preferably amounts to at least 50 weight % and especially at least 95 weight %.
  • The stabilizer component of the liquid concentrate is chosen from formic acid, sodium formate, potassium formate, formic acid propylene glycol mono- or diester or formate esters formed in situ or any mixture thereof, in particular formic acid. 85% or 98-100% formic acid can, for example, be used.
  • The stabilizer component, is present therein in an amount of 0.001 to 20 weights, preferably 0.05 to 10weight %, more preferably still 0.05 to 5 or to 2 weight % and for example less than 2 or less than 0.5 weight % or even less than 0.2 weight %.
  • The liquid concentrate can comprise additional active agents, functional additives and/or auxiliaries.
  • Polybiguanide (frequently also described as polyhexamethylenebiguanide hydrochloride) and/or a polybiguanide salt is possible as additional active agent, preferably in an amount, with reference to the total weight, of 0.1 up to 20 weight %, more preferably up to 5 weight %, particularly preferably up to 2 weight % and most preferably up to 1 weight %. For example, a 20% polyhexamethylenebiguanide hydrochloride in anhydrous or virtually anhydrous grade can be used.
  • The weight ratio of IPBC to polybiguanide or polybiguanide salt is in a preferred embodiment 100:1 to 1:100, preferably 10:1 to 1:10 and more preferably 1:2 to 2:1.
  • In an additionally preferred embodiment, the concentrate comprises ≦1 weight % of IPBC, in particular 1 weight %, and ≦1 weight % of polybiguanide/polybiguanide salt, in particular 0.95 weight %.
  • Depending on the field of application, it may be advantageous if the liquid concentrate is either anhydrous or comprises water as auxiliary, the content of water then preferably amounting to, based on the total weight, 0.01 up to 10 weight %, more preferably up to 5 weight %, more preferably still up to 4.5 or up to 4 weight %, particularly preferably up to 0.2 weight % (virtually anhydrous). The liquid concentrates are preferably anhydrous or virtually anhydrous.
  • The liquid concentrate can comprise, as additional active agent, in addition to or in place of the polybiguanide compound, a paraben, in particular methyl-, ethyl-, propyl- or butylparaben, a quaternary ammonium compound, in particular polyhexamethylene-biguanide or a salt thereof, a benzalkonium salt, in particular benzalkonium chloride, formaldehyde or a formaldehyde-depositing compound or a salt thereof, in particular dimethyloldimethylhydantoin (DMDMH), imidazolidinylurea, diazolidinylurea, hexetidine, 5-bromo-5-nitro-1,3-dioxane (bronidox), 2-bromo-2-nitro-1,3-propanediol (bronopol), 1,3,5,7-tetraazaadamantane (hexamethylenetetramine), 4,4-dimethyl1,3-oxazolidine, benzyl alcohol hemiformal, 5-ethyl-1-aza-3,7-dioxabicyclo[3.3.0]octane, 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride or mixtures thereof, phenoxyethanol, phenoxypropanol, benzyl alcohol, a halogen compound, in particular dibromodicyanobutane (DBDCB), an amidine compound, in particular hexamidine or dibromohexamidine, or a salt thereof, or an isothiazolone, in particular N-methylisothiazolone or N-octylisothiazolone, or any mixture of the abovementioned compounds.
  • Preferred antimicrobial active agents which can be used to improve the effectiveness and/or to broaden the spectrum of activity are o-phenylphenol and its salts, zinc pyrithione, inorganic sulphites and bisulphites, sodium iodate, dibromohexamidine and its salts, triclocarban, 4-chloro-m-cresol, triclosan, 4-chloro-3,5-dimethylphenol, 2-hydroxy-4,4′-dichlorophenyl ether (e.g. Tinosan HP 100), polyhexamethylenediguanide and its salts, 1-(4-chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethyl-2-butanone, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) -2-pyridone and its monoethanolamine salt, 1,2-dibromo-2,4-dicyanobutane, bromochlorophen, 5-chloro-2-methyl-3(2H)-isothiazolone, 2-methyl-3(2H)-isothiazolone, 2-benzyl-4-chlorophenol, 2-chloroacetamide, chlorohexidine and its salts, N-[(C12-C22)alkyltrimethyl]ammonium salts, hexamidine and its salts, glutaraldehyde, silver chloride, benzethonium chloride, benzalkonium salts (e.g. benzalkonium chloride), or mixtures of the abovementioned compounds.
  • In addition, a large number of substances or combinations of substances can be used as additional functional additives, auxiliaries or active agents (cosmetic additives) for the basic formulation (in place of the acids mentioned below, the corresponding salts are optionally used). The additives can be anion-active or cation-active. Examples of additives are skin care substances and moisture-retaining factors (e.g. urea or Sensiva SC 50), complexing agents (e.g. EDTA), essential oils and natural extracts, amphoteric surfactants, surfactants, cleaning additives and disinfection active agents (e.g. cocoamidopropyl betaine), fragrances, antiacne or antidandruff active agents (e.g. octopirox and Lipacid C8G), fungicides, dyes, corrosion inhibitors, disinfection active agents and antiseptics (e.g. octenidine dihydrochloride), bitter principals (e.g. denatonium salts), screening agents (e.g. 2-phenylbenzimidazolesulphonic acid), deodorant active agents (e.g. zinc phenolsulphonate or Sensiva SC 50), oral care active agents (e.g. potassium monofluorophosphate), isothiazolones, carbohydrate compounds (e.g. alkylpolyglycosides, starch or cellulose derivatives and cyclodextrins), alkali metal chlorides (e.g. NaCl or KCl), anionic surfactants (e.g. lauryl ether sulphates), plant extracts and oils. Quaternary ammonium salts (e.g. cetyltrimethylammonium chloride or bromide, cetylpyridinium chloride or didecyldimethylammonium chloride) can be used as possible cation-active active agents.
  • Many of these cosmetic additives also have a multifunctional action. In some cases, synergistic increases in activity of the liquid concentrates according to the invention with the additives may also arise.
  • Additional additives, auxiliaries and/or active agents are, for example, thickeners, buffers, antifoaming agents, solubility promoters, antistatic agents, polymers and/or antioxidants.
  • In individual cases, the type and amount of additional active agents can be established by a person skilled in the art in a simple and rapid manner by a few experiments, it being possible for the active agent system obtained, which includes the liquid concentrate according to the invention, to have a broad or also very specific application potential.
  • The preparation of the concentrates is carried out by simple mixing. For example, the solid components are dissolved with stirring in the liquid components and the additional additives and auxiliaries are stirred in homogeneously. The mixture is optionally heated (e.g. up to 50° C.
  • With regard to the preparation process, in which the constituents are mixed with one another in any sequence, it is optionally advantageous for the liquid concentrate to be stirred or allowed to stand at an increased temperature for a period of time. This temperature treatment results in a surprisingly increased stability. In the course of this, the mixture is advantageously, subsequent to the mixing together, held for 0.5 to 48 hours at a temperature of 30 to 70° C., optionally with stirring, in particular 30 up to 60° C., more preferably at 30 up to 50° C. For example, a temperature treatment over 6 h at 50° C., 24 h at 40° C. or 48 h at 30° C. is possible. The higher the temperature, the shorter the period of time of the temperature treatment can be.
  • It is advantageous that the liquid concentrates according to the invention can be incorporated in the cosmetic and pharmaceutical products by simple dilution. This offers handling and cost advantages compared with the use of individual substances, which are often powders or granules and have to be dissolved or dispersed before incorporation in the product to be preserved. Storage and transportation costs can also be reduced by the concentrate form.
  • A further advantage is that the liquid concentrates according to the invention are suitable as solubility promoters for cosmetic additives with little or limited solubility in water or as solvents or carriers for various cosmetic additives.
  • The liquid concentrate according to the invention preferably exists as a clear homogeneous solution. However, should precipitates possibly arise at a low pH in the concentrate or in predilutions, these can be reversibly dissolved by simple dilution or by correcting the pH. However, it is also possible to prepare the liquid concentrate as a homogeneous-disperse preparation, it being preferable in such cases to avoid relatively large amounts of crystallized active agents in the preparation. In addition, the liquid concentrate can exist in the form of a paste.
  • In a preferred embodiment, an “aged” mixture of glycols and/or glycol ethers and formic acid is used as carrier/stabilizer combination. The expression “aged” means in this connection that combinations of glycols and/or glycol ethers and. formic acid are held at an increased temperature (up to boiling point of the mixture) for a sufficiently long period of time, optionally with stirring, until the smell of formic acid has largely or completely disappeared. Ester formation between the formic acid and the glycol and/or glycol ether possibly occurs during this ageing, the exact structure of the compounds formed being unknown. Alternatively, glycol (ether) formates can also be dissolved in glycol and/or glycol ether and the combination can be used together with the IPBC.
  • Liquid concentrates which smell very little or not at all of formic acid are particularly preferred.
  • The pH of the liquid concentrate is 1 to 10, preferably 3 to 7 and preferably 5 to 7 (measured after preparation of a fresh solution or emulsion with water). For example, the pH of a 2 weight % solution/emulsion in water ranges from 2.5 to 5.5 or approximately 3.
  • The liquid concentrates according to the invention therefore have, in particular, the following advantages:
    • liquid;
    • concentrate form;
    • handling and cost advantages;
    • homogeneous;
    • limpid;
    • low viscosity;
    • colourless to faintly coloured;
    • odourless or virtually odourless;
    • very good thermal stability;
    • very good colour stability;
    • very good active agent stability;
    • broad spectrum of activity with improved (synergistic) effectiveness compared with known IPBC products;
    • can, during the production of cosmetics, serve as solvent, solubility promoter or carrier for other ingredients (e.g. fragrance, or the like);
    • safe—no residue risk upon use;
    • stable at low temperatures, liquid and pumpable at low temperatures (even after 12 months at, e.g., −5° C.); and
    • miscible, compatible with a wide range of ingredients.
  • The liquid concentrates according to the invention are suitable for the preparation of cosmetic products, in particular for leave-on products, such as creams, lotions, gels or moist wipes, the pH values of which generally range from 5 to 8, or for rinse-off products, such as shampoos, the pH values of which are generally less than 7, in particular less than 6.
  • Furthermore, the liquid concentrates according to the invention are suitable as additive for pharmaceutical products and for washing, cleaning, care, body care and hygiene products. In addition to the preservation, the concentrates according to the invention contribute to the antimicrobial effectiveness.
  • The invention is illustrated below by means of examples.
    • EXAMPLES
  • In the examples and comparative examples, polybiguanide was used as a 20 weight % product in water; i.e. 4.75 weight % of 20% polybiguanide corresponds to 0.95 weight % of active agent.
  • The following formulations were prepared by introducing the liquid carrier, adding the IPBC and the polybiguanide and then stirring until a clear solution was formed. The stabilizer was then added and homogeneously distributed with stirring. Clear solutions were obtained by doing this.
    • Example 1
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
    2.50 weight % 98-100% Formic acid
    91.75 weight %  Triethylene glycol
    • Example 2
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
    0.50 weight % 97% Sodium formate
    93.75 weight %  1,3-Butanediol
    • Example 3
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
    2.90 weight % Formic acid (85% in water)
    91.35 weight %  1,2-Propylene glycol
    • Example 4
  • 0.95 weight % IPBC
    4.75 weight % 20% Polybiguanide
    2.20 weight % Formic acid (85% in water)
    92.10 weight %  1,2-Propylene glycol
    • COMPARATIVE EXAMPLES Comparative Example 1
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
    94.25 weight %  1,2-Propylene glycol
    • Comparative Example 2
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
    94.25 weight %  Triethylene glycol
    • Comparative Example 3
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
     1.0 weight % Glycolic acid
    93.25 weight %  Triethylene glycol
    • Comparative Example 4
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
     1.0 weight % Lactic acid (80-90%)
    93.25 weight %  Triethylene glycol
    • Comparative Example 5
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
     1.0 weight % Benzoic acid (>99.5%)
    93.25 weight %  Triethylene glycol
    • Comparative Example 6
  • 1.00 weight % IPBC
    4.75 weight % 20% Polybiguanide
     1.0 weight % Formic acid (98-100%)
    93.25 weight %  Phenoxyethanol
  • The examples according to the invention all showed good stability with regard to odour, colour and active agent, while the products of the comparative examples did not display sufficient stability with regard to odour, colour and active agent.
  • The results of these investigations are collated in Tables 1 and 2.
  • TABLE 1
    Storage stability, low-temperature stability and colour stability of the liquid conc ntrates
    Example 1 Example 3 Example 4 Comparative Example 1
    Appearance immediately clear liquid/ clear liquid/ clear liquid/ clear liquid/almost
    after preparation colourless colourless colourless colourless
    Zero values Odour pungent pungent pungent almost neutral
    Colour number/Hazen 14 6 6 27
    IPBC (%) 1.00 0.96 0.92 0.98
    Polybiguanide (%) 0.97 0.94 0.98 0.98
    3 Months storage in blue polyethylene bottles
    Appearance All samples through all following storage conditions o.V. (clear liquids)
    −5° C. Odour not pungent not pungent not pungent almost neutral
    Colour number/Hazen 99 6 7 74
    IPBC (%) 0.98 1.00 0.94 0.98
    Polybiguanide 1.00 0.94 0.93 1.01
     4° C. Odour not pungent not pungent not pungent almost neutral
    Colour number/Hazen 64 97 8 553
    IPBC (%) 0.98 0.99 0.93 0.98
    Polybiguanide 1.01 0.95 0.94 1.01
    25° C. Odour not pungent not pungent not pungent almost neutral
    Colour number/Hazen 33 16 16 346
    IPBC (%) 0.97 0.97 0.89 0.88
    Polybiguanide 1.02 0.96 0.96 1.02
    ATL (ambient Odour not pungent not pungent not pungent almost neutral
    temperature/light) Colour number/Hazen 30 9 10 422
    IPBC (%) 0.97 0.97 0.95 0.87
    Polybiguanide 1.01 0.96 0.95 1.01
    Window/South Odour not pungent not pungent not pungent almost neutral
    Colour number/Hazen 78 22 21 773
    IPBC (%) 0.94 0.96 0.95 0.77
    Polybiguanide 1.02 0.97 0.97 1.02
    40° C. Odour not pungent not pungent not pungent almost neutral
    Colour number/Hazen 189 568 495 560
    IPBC (%) 0.88 0.65 0.66 0.58
    Polybiguanide 1.04 1.01 1.00 1.03
  • TABLE 2
    Storage stability, low-temperature stability and colour stability of liquid concentrates according to the invention
    Comparative Comparative Comparative Comparative
    Example 3 Example 4 Example 5 Example 6 Example 2
    Appearance immediately clear, colourless clear, colourless clear, colourless clear, colourless clear, colourless
    after preparation
    Hazen colour number 7 9 9 5 5
    Odour characteristic characteristic characteristic pungent not pungent
    IPBC content 0.98 1.01 1.03 1.01 1.00
    After storage for 4 weeks at ambient temperature/light in a glass jar:
    Appearance clear clear clear clear clear
    Hazen colour number >1 000 >1 000 >1 000 >1 000 5
    Gardner colour number 6.4 6.4 5.8 0 0
    Odour o.V. o.V. o.V. not pungent o.V.
    After storage for 4 weeks at +50° C. in a glass jar:
    Appearance clear clear clear clear clear
    Hazen colour number >1 000 >1 000 >1 000 >1 000 122
    Gardner colour number 5.4 5.4 5.5 6.6 0.4
    Odour o.V. o.V. o.V. not pungent o.V.
    IPBC content 0.76% 0.74% 0.72% 0.45% 0.96%
    IPBC loss in % 22% 27% 30% 55% 4%
  • It follows from Tables 1 and 2 that the liquid concentrate according to the invention show a clearly improved stability.
  • For the colour stability investigations, the liquid concentrates were stored in clear glass and the Hazen or Gardner colour number (see test methods) was determined immediately after preparation on a freshly produced preparation, and also after the period of time given and storage at the temperatures given,
    • Test Methods:
  • The Hazen colour number (DIN-ISO 6271, also known as “APHA method” or “platinum/cobalt scale”) is defined as mg of platinum per 1 litre of solution. For the Hazen stock solution, 1.246 g of potassium hexachloroplatinate(IV) and 1.00 g of cobalt(II) chloride are dissolved in 100 ml of hydrochloric acid and made up to 1,000 ml with distilled water, The Hazen colour scale is used for assessing the colour of products which are almost limpid. It is graduated more closely in the light-yellowish region than the iodine colour scale and extends as far as limpid shades of colour.
  • The Gardner colour number is defined in DIN-ISO 4630. The light-yellow Gardner colour numbers (1 to 8) are based on potassium chloroplatinate solutions and the colour numbers 9 to 18 on iron(III) chloride, cobalt(II) chloride and hydrochloric acid solutions.
  • The respective concentrate was introduced into a cell and then the colour number was measured using a colorimeter of Lico® 2 00 type (Dr Lange GmbH, Berlin).
  • The odour development was examined organoleptically. The odours were in each case assessed by 3 people.

Claims (22)

1. A method for preserving cosmetic and pharmaceutical products comprising the steps of:
providing a liquid concentrate preservative comprising:
a) 3-iodo-2-propynyl butylcarbamate (IPBC).
b) at least one liquid carrier,
c) at least one stabilizer, and
d) polyhexamethylene biguanide, or a salt thereof; and
mixing said concentrate in a cosmetic or pharmaceutical product by simple dilution, wherein,
the weight ratio of said IPBC to said polyhexamethylene biguanide is from about 100:1 to about 1:100, and
no additional carboxylic acid chosen from benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid, and 10-undecylenic acid, or the salts thereof, is present in said concentrate.
2. The method according to claim 1, wherein said IPBC is from about 0.01% to about 20% by weight of said concentrate.
3. The method according to claim 1, wherein said liquid carrier comprises at least one component selected from the group consisting of polyvalent alcohols, glycol esters, and glycol ethers.
4. The method according to claim 3, wherein said polyvalent alcohol is at least one component selected from the group consisting of diol, glycol, ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,3-pentanediol. 1,4-pentanediol, 1,5-pentanediol, glycol ester, glycol ether, ethylene glycol, propylene glycol, butylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, triethylene glycol, and 1,2-propylene glycol.
5. The method according to claim 1, wherein said stabilizer comprises at least one component selected from the group consisting of formic acid, formate salts, formate esters, sodium formate, potassium formate, and formic acid propylene glycol monoester, diester, and formate esters formed in situ.
6. The method according to claim 5, wherein said stabilizer consists of formic acid.
7. The method according to claim 1, wherein said stabilizer is from about 0.001% to about 20% by weight of said concentrate.
8. The method according to claim 1, wherein said concentrate further comprises a component selected from the group consisting of at least one functional additive, at least one auxiliary, and mixtures thereof.
9. The method according to claim 1, wherein said polyhexamethylene biguanide is up to about 20% by weight of said concentrate.
10. The method according to claim 1, wherein said weight ratio ranges from about 10:1 to about 1:10.
11. The method according to claim 1, wherein said IPBC is less than about 1% by weight of said concentrate, and said polyhexamethylene biguanide is less than about 1% by weight of said concentrate.
12. The method according to claim 1, wherein,
said concentrate further comprises at least one functional additive, and
said concentrate is absent an auxiliary.
13. The method according to claim 8, wherein said auxiliary comprises water.
14. The method according to claim 13, wherein said water is from about 0.01% to about 10% by weight of the concentrate.
15. The method according to claim 8, wherein said concentrate further comprises a paraben.
16. The method according to claim 8, wherein said concentrate further comprises a quaternary ammonium compound.
17. The method according to claim 8, wherein said concentrate further comprises a halogen compound.
18. The method according to claim 8, wherein said concentrate further comprises an amidine compound.
19. The method according to claim 8, wherein said concentrate further comprises isothiazolone.
20. The method according to claim 8, wherein said concentrate further comprises benzalkonium salt.
21. The method according to claim 8, wherein said concentrate further comprises formaldehyde or a formaldehyde-depositing compound or a salt thereof.
22. The method according to claim 8, wherein said concentrate further comprises at least one of phenoxyethanol, phenoxypropanol, and benzyl alcohol.
US12/049,397 2002-08-27 2008-03-17 Liquid concentrate for the preservation of cosmetic and pharmaceutical products Abandoned US20080161392A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/049,397 US20080161392A1 (en) 2002-08-27 2008-03-17 Liquid concentrate for the preservation of cosmetic and pharmaceutical products

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10239238.2 2002-08-27
DE10239238A DE10239238A1 (en) 2002-08-27 2002-08-27 Liquid concentrate for the preservation of cosmetic and pharmaceutical products
US10/649,167 US7364746B2 (en) 2002-08-27 2003-08-26 Liquid concentrate for the preservation of cosmetic and pharmaceutical products
US12/049,397 US20080161392A1 (en) 2002-08-27 2008-03-17 Liquid concentrate for the preservation of cosmetic and pharmaceutical products

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/649,167 Division US7364746B2 (en) 2002-08-27 2003-08-26 Liquid concentrate for the preservation of cosmetic and pharmaceutical products

Publications (1)

Publication Number Publication Date
US20080161392A1 true US20080161392A1 (en) 2008-07-03

Family

ID=31197417

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/649,167 Expired - Fee Related US7364746B2 (en) 2002-08-27 2003-08-26 Liquid concentrate for the preservation of cosmetic and pharmaceutical products
US12/049,397 Abandoned US20080161392A1 (en) 2002-08-27 2008-03-17 Liquid concentrate for the preservation of cosmetic and pharmaceutical products

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/649,167 Expired - Fee Related US7364746B2 (en) 2002-08-27 2003-08-26 Liquid concentrate for the preservation of cosmetic and pharmaceutical products

Country Status (5)

Country Link
US (2) US7364746B2 (en)
EP (1) EP1393713B1 (en)
JP (1) JP2004099611A (en)
DE (3) DE10239238A1 (en)
ES (1) ES2259748T3 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014616A1 (en) * 2004-03-23 2005-10-13 Beiersdorf Ag Microbially stable cosmetic or dermatological light-protective skin care preparations, containing taurine and paraben, sorbic acid or (3-iodo-2-propynyl) N-butylcarbamate
DE102005012123A1 (en) * 2005-03-16 2006-09-28 Schülke & Mayr GmbH Isothiazolone-containing preservative with improved effectiveness
US20090123397A1 (en) * 2005-07-11 2009-05-14 Thor Specialities (Uk) Limited Microbiocidal compositions
EP1772055A1 (en) * 2005-10-04 2007-04-11 Rohm and Haas France SAS Synergistic microbicidal compositions comprising a N-alkyl-1,2-benzoisothiazolin-3-one
EP1825750B1 (en) * 2006-02-22 2009-07-01 Menno Chemie-Vertrieb GmbH System for delivering agricultural chemicals
JP2008119433A (en) * 2006-11-15 2008-05-29 Daiwa Kagaku Kogyo Kk How to save paper towels and hand towels
EP2480074A4 (en) * 2009-09-21 2013-09-25 Holden Brien Vision Inst Contact lens disinfecting solutions
EP3013307B1 (en) 2013-06-27 2018-07-25 The Procter and Gamble Company Personal care articles
DE102013226426A1 (en) * 2013-12-18 2015-06-18 Henkel Ag & Co. Kgaa Preservative system for detergents
WO2016209966A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
DE102015116835A1 (en) * 2015-10-05 2017-04-06 Minasolve Germany Gmbh Stable solution of hexamidine salts in alkanediol-water mixtures with anti-microbial and skin-moisturizing action
DE102015223817A1 (en) * 2015-12-01 2017-06-01 Henkel Ag & Co. Kgaa Powerful hair treatment agent with structure-strengthening effect
KR102166918B1 (en) * 2016-08-08 2020-10-19 오토노믹 머터리얼즈, 아이엔씨. Biocidal protection formulation
JP7078819B2 (en) * 2017-04-28 2022-06-01 日本製紙クレシア株式会社 Wet wiper
KR102811803B1 (en) * 2022-11-02 2025-05-27 주식회사 에스엠이 Composition for promoting plant growth and inhibiting over growth comprising organic iodine as active gradient

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172117B1 (en) * 1998-02-27 2001-01-09 Akzo Nobel N.V. Biocidal preservatives
US6375727B1 (en) * 1999-05-24 2002-04-23 Lonza Inc. Amine oxide/iodine containing blends for wood preservation
US20030032768A1 (en) * 2001-07-18 2003-02-13 Richard Stockel Double end-capped polymeric biguanides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026756C2 (en) * 1990-08-24 1995-03-23 Turner Gmbh Preservatives and their use
JP3585176B2 (en) * 1992-07-22 2004-11-04 シントーファイン株式会社 Industrial antifungal composition
US5470875A (en) * 1995-01-06 1995-11-28 Isp Chemicals Inc. Water soluble, antimicrobial compositions of polyhexamethylene biguanide and iodopropynylbutyl carbamate
US6143204A (en) * 1998-06-19 2000-11-07 Lonza Inc. Stabilization of iodopropynl compounds
DE19922538A1 (en) * 1999-05-10 2000-11-16 Schuelke & Mayr Gmbh Liquid concentrate for the preservation of cosmetics
DE10034137A1 (en) * 2000-07-13 2002-01-24 Beiersdorf Ag Active ingredient combinations of 3-iodo-2-propynyl butyl carbamate and one or more 4-hydroxybenzoic acid esters and preparations containing such active ingredient combinations
DE10034138A1 (en) * 2000-07-13 2002-01-24 Beiersdorf Ag Active ingredient combinations of 3-iodo-2-propynyl butyl carbomate and phenoxyethanol and preparations containing such active ingredient combinations
DE10034136A1 (en) * 2000-07-13 2002-01-24 Beiersdorf Ag Active ingredient combinations of 3-iodo-2-propynyl butyl carbamate, one or more 4-hydroxybenzoic acid esters and phenoxyethanol and preparations containing such active ingredient combinations
EP1206933B1 (en) * 2000-11-16 2006-05-17 Johnson & Johnson Consumer France SAS Compositions comprising caprylyl glycol and iodopropynyl butylcarbamate
CN1315382C (en) * 2001-03-01 2007-05-16 隆萨公司 Combination of iodopropynyl derivative with ketone acid or its salt and/or with aromatic carboxylic acid or its salt

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172117B1 (en) * 1998-02-27 2001-01-09 Akzo Nobel N.V. Biocidal preservatives
US6375727B1 (en) * 1999-05-24 2002-04-23 Lonza Inc. Amine oxide/iodine containing blends for wood preservation
US20030032768A1 (en) * 2001-07-18 2003-02-13 Richard Stockel Double end-capped polymeric biguanides

Also Published As

Publication number Publication date
DE60303735T4 (en) 2008-06-05
DE10239238A1 (en) 2004-03-18
DE60303735D1 (en) 2006-04-27
DE60303735T2 (en) 2008-04-03
EP1393713A1 (en) 2004-03-03
JP2004099611A (en) 2004-04-02
EP1393713B1 (en) 2006-03-01
US7364746B2 (en) 2008-04-29
US20050100567A1 (en) 2005-05-12
ES2259748T3 (en) 2006-10-16

Similar Documents

Publication Publication Date Title
US20080161392A1 (en) Liquid concentrate for the preservation of cosmetic and pharmaceutical products
US8501206B2 (en) Liquid concentrate for preserving cosmetics
US7384646B2 (en) Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same
US20060093634A1 (en) Personal care compositions and concentrates for making the same
EP2594248B1 (en) Active ingredient combination and use thereof
US9883671B2 (en) Mixture of natural or nature-identical alcohols with improved effectiveness
JP4209686B2 (en) Alcohol-free liquid concentrate for storing beauty products, household products and industrial products
EP4391809A2 (en) Antimicrobial combinations
WO2019002223A1 (en) Use of alkylresorcinols for improving the activity of cosmetics preservatives
JP5372311B2 (en) Stabilizer composition based on monoalkyl glycerol ether and aromatic alcohol
US20160310382A1 (en) Composition comprising ferulic acid ethyl ester and aryl alkanol

Legal Events

Date Code Title Description
AS Assignment

Owner name: L'AIR LIQUIDE SANTE (INTERNATIONAL), FRANCE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HAHN, GISELA;WEBER, KLAUS;GRADTKE, RALF;AND OTHERS;REEL/FRAME:020657/0799

Effective date: 20030716

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION